Institutions / Barclays PLC / Activity
Activity — Barclays PLC
49,937 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q4 2025 as of | Exit | BEAT HeartBeam, Inc. Common Stock | $-26 | -16 -100.00% | 0 | low |
| Q4 2024 as of | Exit | DNA X, Inc. Common stock | $-26 | -9 -100.00% | 0 | low |
| Q3 2024 as of | New | DNA X, Inc. Common stock | $26 | +9 | 9 0.00% of portfolio | low |
| Q1 2023 as of | Trim | 91842V110 Common stock | $-27 | -600 -1.86% | 31,700 <0.01% of portfolio | low |
| Q4 2023 as of | Trim | 46141D203 Common stock | $-27 | -1 -33.33% | 2 0.00% of portfolio | low |
| Q4 2024 as of | Exit | Rezolve Ai PLC Common stock | $-27 | -4 -100.00% | 0 | low |
| Q4 2024 as of | Exit | SAB Biotherapeutics, Inc. Common stock | $-27 | -10 -100.00% | 0 | low |
| Q3 2024 as of | New | Rezolve Ai PLC Common stock | $27 | +4 | 4 0.00% of portfolio | low |
| Q3 2024 as of | New | SAB Biotherapeutics, Inc. Common stock | $27 | +10 | 10 0.00% of portfolio | low |
| Q3 2025 as of | New | Adagio Medical Holdings, Inc. Common stock | $27 | +14 | 14 0.00% of portfolio | low |
| Q4 2025 as of | Exit | Adagio Medical Holdings, Inc. Common stock | $-27 | -14 -100.00% | 0 | low |
| Q2 2025 as of | Add | 185064102 Common stock | $28 | +49 +1225.00% | 53 0.00% of portfolio | low |
| Q1 2025 as of | New | Coeptis Therapeutics Holdings Inc Common stock | $28 | +3 | 3 0.00% of portfolio | low |
| Q3 2025 as of | New | VELO Velo3D, Inc. Common Stock | $28 | +9 | 9 0.00% of portfolio | low |
| Q3 2025 as of | New | 17259U204 Common stock | $28 | +3 | 3 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 17259U204 Common stock | $-28 | -3 -100.00% | 0 | low |
| Q3 2024 as of | New | 45674E109 Common stock | $28 | +102 | 102 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 45674E109 Common stock | $-28 | -102 -100.00% | 0 | low |
| Q4 2025 as of | Trim | GBLI Global Indemnity Group, LLC Common Stock | $-28 | -1 -50.00% | 1 0.00% of portfolio | low |
| Q4 2023 as of | New | VHC VirnetX Holding Corp Common Stock | $28 | +4 | 4 0.00% of portfolio | low |
| Q2 2023 as of | Exit | 464286806 Common stock | $-28 | -1 -100.00% | 0 | low |
| Q3 2025 as of | Add | Unifi, Inc. Common stock | $29 | +6 +0.15% | 3,877 <0.01% of portfolio | low |
| Q1 2024 as of | Add | TISI Team Inc Common Stock | $29 | +4 +<0.01% | 215,004 <0.01% of portfolio | low |
| Q1 2025 as of | New | 02008G201 Common stock | $29 | +9 | 9 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 02008G201 Common stock | $-29 | -9 -100.00% | 0 | low |
| Q2 2024 as of | New | 28202V207 Common stock | $29 | +100 | 100 0.00% of portfolio | low |
| Q4 2025 as of | New | TWFG, Inc. Common stock | $29 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | New | 68557F209 Common stock | $29 | +35 | 35 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 68557F209 Common stock | $-29 | -35 -100.00% | 0 | low |
| Q1 2025 as of | Exit | 56854Q200 Common stock | $-29 | -54 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 70387R403 Common stock | $-29 | -69 -100.00% | 0 | low |
| Q3 2025 as of | New | 70387R403 Common stock | $29 | +69 | 69 0.00% of portfolio | low |
| Q3 2025 as of | New | LONA LeonaBio, Inc. Common Stock | $29 | +7 | 7 0.00% of portfolio | low |
| Q4 2025 as of | Exit | LONA LeonaBio, Inc. Common Stock | $-29 | -7 -100.00% | 0 | low |
| Q2 2024 as of | Trim | Precision BioSciences, Inc. Common stock | $-29 | -3 -0.10% | 2,870 <0.01% of portfolio | low |
| Q3 2024 as of | Add | 863685202 Common stock | $29 | +20 +333.33% | 26 0.00% of portfolio | low |
| Q3 2025 as of | New | ANIX Anixa Biosciences Inc Common Stock | $30 | +9 | 9 0.00% of portfolio | low |
| Q3 2025 as of | New | 754198109 Common stock | $30 | +9 | 9 0.00% of portfolio | low |
| Q4 2025 as of | Exit | ANIX Anixa Biosciences Inc Common Stock | $-30 | -9 -100.00% | 0 | low |
| Q4 2025 as of | Exit | 754198109 Common stock | $-30 | -9 -100.00% | 0 | low |
| Q3 2024 as of | New | 78464A474 Common stock | $30 | +1 | 1 0.00% of portfolio | low |
| Q3 2025 as of | Exit | CYPH Cypherpunk Technologies Inc. Common Stock | $-30 | -100 -100.00% | 0 | low |
| Q3 2024 as of | New | 45783Y848 Common stock | $30 | +1 | 1 0.00% of portfolio | low |
| Q3 2023 as of | Add | 46141D203 Common stock | $30 | +1 +50.00% | 3 0.00% of portfolio | low |
| Q3 2023 as of | Exit | 92671V106 Common stock | $-30 | -248 -100.00% | 0 | low |
| Q2 2024 as of | Exit | 483709101 Common stock | $-30 | -14 -100.00% | 0 | low |
| Q3 2024 as of | Trim | BioXcel Therapeutics, Inc. Common stock | $-30 | -49 -35.77% | 88 0.00% of portfolio | low |
| Q4 2023 as of | New | Dianthus Therapeutics, Inc. Common stock | $31 | +3 | 3 0.00% of portfolio | low |
| Q4 2024 as of | Exit | 74347G382 Common stock | $-31 | -3 -100.00% | 0 | low |
| Q3 2025 as of | New | 108763103 Common stock | $31 | +4 | 4 0.00% of portfolio | low |